Irwin Naturals (OTC:IWINF – Get Rating) had its target price trimmed by Cantor Fitzgerald from $6.20 to $6.00 in a research report sent to investors on Monday, Benzinga reports. The firm currently has an overweight rating on the stock.
Several other equities research analysts have also recently commented on IWINF. Maxim Group initiated coverage on shares of Irwin Naturals in a research report on Friday. They issued a buy rating on the stock. HC Wainwright assumed coverage on shares of Irwin Naturals in a report on Monday, October 3rd. They issued a buy rating and a $5.00 target price on the stock.
Irwin Naturals Stock Performance
IWINF opened at $2.85 on Monday. The stock has a fifty day moving average price of $2.55. Irwin Naturals has a one year low of $1.08 and a one year high of $3.97.
Irwin Naturals Company Profile
Irwin Naturals Inc, a herbal supplement company, distributes CBD products in the United States and internationally. It offers its products online, as well as through approximately 100,000 stores. The company was formerly known as Datinvest International Ltd. The company is based in Los Angeles, California.
- Get a free copy of the StockNews.com research report on Irwin Naturals (IWINF)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Irwin Naturals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irwin Naturals and related companies with MarketBeat.com's FREE daily email newsletter.